Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis ; volume:19 ; number:1 ; day:19 ; month:12 ; year:2024 ; pages:1-8 ; date:12.2024
Journal of cardiothoracic surgery ; 19, Heft 1 (19.12.2024), 1-8, 12.2024
- Creator
-
Wang, Hui
Wu, Sensen
Meng, Wenzhuo
Pan, Dikang
Ning, Yachan
Guo, Jianming
Guo, Lianrui
Gu, Yongquan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13019-024-03164-1
- URN
-
urn:nbn:de:101:1-2503020640019.999887769533
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
08.08.2202, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Hui
- Wu, Sensen
- Meng, Wenzhuo
- Pan, Dikang
- Ning, Yachan
- Guo, Jianming
- Guo, Lianrui
- Gu, Yongquan
- SpringerLink (Online service)
Other Objects (12)
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
Evaluation of femoropopliteal in-stent restenosis characteristics stratified by stent design
Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
Enabling Angioplasty‐Ready “Smart” Stents to Detect In‐Stent Restenosis and Occlusion
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-Coated Balloons for Restenosis Prophylaxis
In-stent restenosis in real world
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs
Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie : = Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
Evaluation of femoropopliteal in-stent restenosis characteristics stratified by stent design
Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
Enabling Angioplasty‐Ready “Smart” Stents to Detect In‐Stent Restenosis and Occlusion
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-Coated Balloons for Restenosis Prophylaxis
In-stent restenosis in real world
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs
Vergleich der Laserangioplastie plus medikamentenbeschichtete Ballonangioplastie (DCB) versus alleinige DCB-Angioplastie bei in-stent Restenosen/Verschlüssen der Femoropoplitealen Arterie : = Laserangioplasty plus drug coated balloon (DCB) angioplasty vs. plain DCB angioplasty for treatment of femoro-popliteal in-stent restenosis and occlusion
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
Evaluation of femoropopliteal in-stent restenosis characteristics stratified by stent design
Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
Enabling Angioplasty‐Ready “Smart” Stents to Detect In‐Stent Restenosis and Occlusion
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-Coated Balloons for Restenosis Prophylaxis
In-stent restenosis in real world
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs